(3-Oxabicyclo[3.1.0]hexan-1-yl)methanol, 98%, 500mg

(2E)-3-(2-fluorophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(R)-4-(Dibenzylamino)-3-fluoro-2-methylbutan-2-ol, 97%, 10g

2-(4-tert-Butyl-phenoxy)-2-methyl-propionic acid, 95.0%, 250mg

1-Boc-4-(4-Amino-2-trifluoromethylphenyl)piperazine, 95.0%, 10g

(R)-2-Methoxymethylpyrrolidine hydrochloride, 97.0%, 5g

4-(2-ethoxyphenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

3-(2,2,2-Trifluoro-acetylamino)-thiophene-2-carboxylic acid methyl ester, 95.0%, 250mg

2,4-Dichloro-5-formylthiazole, 97.0%, 1g

2-METHOXY-7,8-DIHYDROQUINOLIN-6(5H)-ONE, 95.0%, 250mg

Quinoxaline-6-carbaldehyde, 95.0%, 10g

1,3,5-Trichloro-2-propoxybenzene, 95%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 0.10 µm, 1 Piece(s)